Not currently enrolling

Eosinophilic Esophagitis drug trial

This study aims to assess the efficacy and safety of Tezepelumab injections as a treatment for EoE.

Age & Gender

12 years ~ 80 years
Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is not currently enrolling.

United States (Nationwide)

Additional Study Information

Principal Investigator

Evan Dellon
Center for Gastrointestinal Biology and Disease

Study Type

Clinical or Medical
Interventional

Study Topics

Allergy
Chronic Conditions
Stomach, Digestion and Gut Health
Eating, Nutrition, and Metabolism
Rare Diseases

IRB Number

22-2865

ClinicalTrials.gov

NCT05583227

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.